Exicure Inc (XCUR): Exicure, Inc. and Bluejay Therapeutics I...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	105
Posts	16334
Boards Moderated	0
Alias Born	06/24/2014

Awl416

Re: None

Monday, 02/05/2024 4:19:26 PM

Monday, February 05, 2024 4:19:26 PM

Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent XCUR News

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K • Business Wire • 04/22/2024 08:01:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 05:15:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:36:01 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/04/2024 10:37:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:16:37 PM
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis • Business Wire • 02/05/2024 09:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:16:29 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 11:14:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:21:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:19:44 PM
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q • Business Wire • 11/28/2023 09:01:00 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:28:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 09:03:29 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 09:05:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 09:25:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 09:03:38 PM
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors • Business Wire • 08/23/2023 01:48:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 01:29:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 10:09:17 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:33:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:18:03 PM
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update • Business Wire • 08/11/2023 08:01:00 PM

More XCUR News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover